Estados financieros detallados de ORIC Pharmaceuticals, Inc. (ORIC): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 0.0%, margen operativo 0.0%, margen neto 0.0%.
Al precio actual de $12.54, ORIC presenta beneficios negativos (P/E no significativo) y un ROE del -35.35%. La capitalización bursátil es de $1.3B.
Cuenta de Resultados (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | $900000 | $900000 | $1.0M | 0 | 0 | 0 | $1.0M | $1.1M | $1.2M |
| Beneficio Bruto | -$900000 | -$900000 | -$1.0M | 0 | 0 | 0 | -$1.0M | -$1.1M | -$1.2M |
| I+D | $19.1M | $19.0M | $22.8M | $60.8M | $56.9M | $61.7M | $85.2M | $114.1M | $109.8M |
| Generales y Administrativos | $2.5M | $3.3M | $4.7M | $13.4M | $22.0M | $25.1M | $25.6M | $28.8M | $33.2M |
| Gastos Operativos | $21.6M | $22.4M | $27.6M | $74.2M | $78.9M | $91.8M | $109.7M | $141.8M | $141.8M |
| Beneficio Operativo | -$22.5M | -$22.4M | -$28.6M | -$74.2M | -$78.9M | -$91.8M | -$110.8M | -$142.9M | -$143.0M |
| EBITDA | -$21.1M | -$20.5M | -$25.9M | -$48.4M | -$77.8M | -$85.8M | -$99.7M | -$126.7M | -$128.2M |
| Gastos por Intereses | 0 | 0 | 0 | 0 | 0 | $2.6M | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$22.0M | -$21.4M | -$26.9M | -$73.7M | -$78.7M | -$89.1M | -$100.7M | -$127.8M | -$129.5M |
| Impuestos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$22.0M | -$21.4M | -$26.9M | -$73.7M | -$78.7M | -$89.1M | -$100.7M | -$127.8M | -$129.5M |
| BPA | $-15.62 | $-12.32 | $-1.40 | $-3.36 | $-2.07 | $-2.25 | $-1.96 | $-1.83 | $-1.47 |
| BPA Diluido | $-15.62 | $-12.32 | $-1.40 | $-3.36 | $-2.07 | $-2.25 | $-1.96 | $-1.83 | $-1.47 |
| Acciones en Circulación (Diluidas) | $1.4M | $1.7M | $19.1M | $21.9M | $38.0M | $39.7M | $51.5M | $69.7M | $87.8M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | 0 | 0 | 0 | 0 |
| Beneficio Bruto | 0 | -$320000 | 0 | -$264000 |
| Beneficio Operativo | -$36.7M | -$34.6M | -$39.6M | -$45.3M |
| EBITDA | -$32.3M | -$30.2M | -$35.5M | -$45.0M |
| Beneficio Neto | -$32.6M | -$30.5M | -$35.8M | -$41.5M |
| BPA | $-0.33 | $-0.30 | $-0.34 | $-0.38 |
| BPA Diluido | $-0.33 | $-0.30 | $-0.34 | $-0.38 |
Balance (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $25.8M | $42.6M | $89.2M | $78.4M | $226.0M | $66.8M | $23.4M | $59.4M | $45.7M |
| Inversiones a Corto | 0 | 0 | 0 | $215.2M | $11.0M | $139.4M | $184.8M | $196.6M | $235.8M |
| Cuentas por Cobrar | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $26.6M | $43.7M | $90.0M | $296.7M | $240.5M | $210.5M | $212.6M | $262.2M | $288.5M |
| Inmovilizado Material | $2.9M | $2.5M | $2.2M | $2.0M | $2.4M | $14.3M | $12.0M | $2.9M | $9.1M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $30.0M | $46.7M | $94.1M | $299.0M | $298.6M | $250.4M | $254.7M | $274.1M | $411.0M |
| Cuentas por Pagar | $940000 | $446000 | $152000 | $757000 | $1.9M | $1.3M | $944000 | $1.5M | $3.8M |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | $2.7M | $2.8M | 0 | $3.3M |
| Pasivos Corrientes | $2.6M | $2.6M | $5.4M | $9.0M | $15.2M | $15.4M | $20.5M | $24.8M | $20.4M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $4.1M |
| Pasivos Totales | $4.3M | $111.2M | $6.1M | $9.2M | $25.7M | $28.0M | $30.6M | $31.0M | $26.6M |
| Reservas | -$44.4M | -$65.8M | -$92.7M | -$166.4M | -$245.1M | -$334.2M | -$434.9M | -$562.8M | -$692.2M |
| Patrimonio Neto | $25.7M | -$64.4M | $88.0M | $289.8M | $273.0M | $222.4M | $224.1M | $243.1M | $384.4M |
| Deuda Total | 0 | 0 | 0 | 0 | $1.9M | $12.1M | $10.2M | $3.2M | $11.6M |
| Deuda Neta | -$25.8M | -$42.6M | -$89.2M | -$293.6M | -$235.1M | -$194.2M | -$198.0M | -$252.8M | -$269.9M |
| Capital Circulante | $24.0M | $41.1M | $84.6M | $287.7M | $225.4M | $195.1M | $192.1M | $237.4M | $268.0M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $49.7M | $45.7M | $56.4M | $37.5M |
| Activos Totales | $431.2M | $411.0M | $436.8M | $404.7M |
| Pasivos Totales | $24.3M | $26.6M | $21.2M | $23.4M |
| Patrimonio Neto | $406.9M | $384.4M | $415.6M | $381.3M |
| Deuda Total | $3.3M | $11.6M | $3.3M | $3.3M |
Flujo de Caja (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$22.0M | -$21.4M | -$26.9M | -$73.7M | -$78.7M | -$89.1M | -$100.7M | -$127.8M | -$129.5M |
| Amortizaciones | $900000 | $903000 | $1.0M | $970000 | $897000 | $966000 | $1.0M | $1.1M | $1.2M |
| Compensación en Acciones | $217 | $469000 | $1.1M | $5.3M | $12.9M | $14.5M | $15.2M | $20.2M | 0 |
| Cambio en Capital Circulante | $95000 | -$707000 | $1.2M | $2.0M | $4.1M | -$445000 | $4.9M | $2.0M | -$5.5M |
| Flujo de Caja Operativo | -$20.8M | -$20.7M | -$23.5M | -$45.3M | -$59.5M | -$75.1M | -$85.7M | -$112.7M | -$113.4M |
| Inversiones (CapEx) | -$486000 | -$525000 | -$768000 | -$667000 | -$939000 | -$2.1M | -$849000 | -$1.2M | -$712000 |
| Adquisiciones | 0 | 0 | 0 | 0 | $1.4M | $2.1M | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$21.3M | -$21.2M | -$24.3M | -$45.9M | -$60.5M | -$77.2M | -$86.5M | -$113.8M | -$114.1M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$25.1M | -$22.5M | -$32.4M | -$31.6M |
| Inversiones (CapEx) | -$35000 | -$387000 | -$2000 | -$356000 |
| Flujo de Caja Libre | -$25.1M | -$22.9M | -$32.4M | -$32.0M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $5.6M | $6.3M | $6.9M | $7.1M |
Crecimiento y Márgenes (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Beneficio Neto (anual) | | +3.0% | -25.8% | -174.2% | -6.8% | -13.2% | -13.0% | -27.0% | -1.3% |
| Crecimiento BPA (anual) | | +21.1% | +88.6% | -140.0% | +38.4% | -8.7% | +12.9% | +6.6% | +19.7% |
| Cambio en Acciones (anual) | | +22.9% | +1003.8% | +14.6% | +73.0% | +4.5% | +29.7% | +35.5% | +25.9% |
| Crecimiento FCF (anual) | | +0.5% | -14.6% | -89.0% | -31.7% | -27.7% | -12.1% | -31.6% | -0.2% |
| Tasa Impositiva Efectiva | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-15.11 | $-12.23 | $-1.27 | $-2.09 | $-1.59 | $-1.95 | $-1.68 | $-1.63 | $-1.30 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $1.4M | $1.7M | $1.9M | $21.9M | $38.0M | $39.7M | $51.5M | $69.7M | $87.8M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -35.35% |
| Rentabilidad sobre capital invertido | -40.32% |
| Rentabilidad sobre activos | -34.68% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Salud financiera
| Deuda / Patrimonio | 0.01 |
| Ratio corriente | 13.19 |
| Piotroski F-Score | 3 |
| Altman Z-Score | 13.45 |
Ratios Clave (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -1.65 | -2.09 | -18.41 | -10.07 | -7.10 | -2.62 | -4.69 | -4.41 | -5.56 |
| P/VC | 1.41 | -0.69 | 0.56 | 2.56 | 2.04 | 1.05 | 2.11 | 2.31 | 1.87 |
| P/V | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Margen Bruto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Operativo | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Neto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |